AUPO434196A0 - An improved therapeutic - Google Patents
An improved therapeuticInfo
- Publication number
- AUPO434196A0 AUPO434196A0 AUPO4341A AUPO434196A AUPO434196A0 AU PO434196 A0 AUPO434196 A0 AU PO434196A0 AU PO4341 A AUPO4341 A AU PO4341A AU PO434196 A AUPO434196 A AU PO434196A AU PO434196 A0 AUPO434196 A0 AU PO434196A0
- Authority
- AU
- Australia
- Prior art keywords
- improved therapeutic
- therapeutic
- improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO4341A AUPO434196A0 (en) | 1996-12-24 | 1996-12-24 | An improved therapeutic |
AU78716/98A AU7871698A (en) | 1996-12-24 | 1997-12-24 | Hepatitis delta particle containing a fusion protein immunogen |
PCT/AU1997/000884 WO1998028004A1 (fr) | 1996-12-24 | 1997-12-24 | Particule de l'hepatite delta contenant un immunogene de proteine de fusion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO4341A AUPO434196A0 (en) | 1996-12-24 | 1996-12-24 | An improved therapeutic |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPO434196A0 true AUPO434196A0 (en) | 1997-01-23 |
Family
ID=3798649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPO4341A Abandoned AUPO434196A0 (en) | 1996-12-24 | 1996-12-24 | An improved therapeutic |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPO434196A0 (fr) |
WO (1) | WO1998028004A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP706098A0 (en) * | 1998-11-11 | 1998-12-03 | North Western Health Care Network | Biological compositions, components thereof and uses therefor |
US7476517B2 (en) | 1999-06-30 | 2009-01-13 | Evotec Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US20040014033A1 (en) | 1999-06-30 | 2004-01-22 | Evotec Biosystems Ag, A Corporation Of Germany | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
AU6267000A (en) * | 1999-06-30 | 2001-01-22 | Evotec Oai Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
AUPQ912000A0 (en) * | 2000-07-31 | 2000-08-24 | Crown In The Right Of The Queensland Department Of Health, The | Improved virus like particles |
AU2001276182B2 (en) * | 2000-07-31 | 2006-05-04 | Monash University | Improved virus like particles based on small envelope protein from hepatitis B (HBsAg-S) |
DE60037263T2 (de) * | 2000-12-29 | 2008-10-09 | Evotec Ag | Virus-ähnliche Partikel, ihre Herstellung und ihre Verwendung beim pharmazeutischen Screening und funktionelle Genomanwendungen |
AU2015210336B2 (en) * | 2010-08-17 | 2017-05-25 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
EP3587574B1 (fr) | 2010-08-17 | 2022-03-16 | Sirna Therapeutics, Inc. | Inhibition médiée par des arn interférents de l'expression génique du virus de l'hépatite b (vhb) à l'aide de petits acides nucléiques interférents (pani) |
AU2012271625B2 (en) | 2011-06-14 | 2017-05-18 | Globeimmune, Inc. | Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection |
JOP20200092A1 (ar) | 2014-11-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها |
US11324820B2 (en) | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
TW202023574A (zh) | 2018-08-13 | 2020-07-01 | 美商阿尼拉製藥公司 | B型肝炎病毒(HBV)dsRNA劑組合物及其使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225347A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Therapeutic ribozyme compositions and expression vectors |
-
1996
- 1996-12-24 AU AUPO4341A patent/AUPO434196A0/en not_active Abandoned
-
1997
- 1997-12-24 WO PCT/AU1997/000884 patent/WO1998028004A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998028004A1 (fr) | 1998-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPO203996A0 (en) | Therapeutic uses | |
AU4040197A (en) | Microturbomachinery | |
AU3387997A (en) | Autonotification | |
AU2845197A (en) | Cycloalkano-pyridines | |
AU4787697A (en) | Therapeutic gene | |
AU4945197A (en) | Aminothiophenecarboxamides | |
AU4013397A (en) | Arylalkanoylpyridazines | |
AU4176997A (en) | 3-alkyl-3-phenyl-piperidines | |
AU2684197A (en) | Handleset | |
AU4218597A (en) | Superseat | |
AU5556998A (en) | 3-amino-1-cyanophenyl-uracils | |
AUPO434196A0 (en) | An improved therapeutic | |
AU2090897A (en) | Hydroxyhexahydropyridazines | |
AU3130597A (en) | Tristetraprolin | |
AU5221598A (en) | Sweet-toy | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU4332497A (en) | Endo-beta-galactosidase | |
AU1900097A (en) | Cremators | |
AU2237197A (en) | Fishing-lure | |
AU4582597A (en) | Therapeutic proteins | |
AU3557397A (en) | Double-tau-profile | |
AU1597197A (en) | Thienoquinolines | |
AU5002897A (en) | Gripper-accumulator | |
AU5330198A (en) | Therapeutic compounds | |
AU1643797A (en) | Repeater-system |